Similarly, activating mutations of GCK causing elevated GCK activity in liver and pancreatic beta-cells are also known to result in persistent hyperinsulinemic hypoglycemia of infancy (HPPI), in which high insulin levels induce low blood glucose levels [5]. The gene discussed is GCK; the disease is hyperinsulinemic hypoglycemia.